Monitoring of system conditioning after blank injections in untargeted UPLC-MS metabolomic analysis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 07 2019
Historique:
received: 05 12 2018
accepted: 25 06 2019
entrez: 10 7 2019
pubmed: 10 7 2019
medline: 22 10 2020
Statut: epublish

Résumé

Ultra-performance liquid chromatography - mass spectrometry (UPLC-MS) is widely used for untargeted metabolomics in biomedical research. To optimize the quality and precision of UPLC-MS metabolomic analysis, evaluation of blank samples for the elimination of background features is required. Although blanks are usually run either at the beginning or at the end of a sequence of samples, a systematic analysis of their effect of the instrument performance has not been properly documented. Using the analysis of two common bio-fluids (plasma and urine), we describe how the injection of blank samples within a sequence of samples may affect both the chromatographic and MS detection performance depending on several factors, including the sample matrix and the physicochemical properties of the metabolites of interest. The analysis of blanks and post-blank conditioning samples using t-tests, PCA and guided-PCA provides useful information for the elimination of background UPLC-MS features, the identification of column carry over and the selection of the number of samples required to achieve a stable performance.

Identifiants

pubmed: 31285473
doi: 10.1038/s41598-019-46371-w
pii: 10.1038/s41598-019-46371-w
pmc: PMC6614502
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9822

Références

Metabolomics. 2018;14(6):72
pubmed: 29805336
Nat Rev Drug Discov. 2016 Jul;15(7):473-84
pubmed: 26965202
AAPS J. 2007 Nov 02;9(3):E353-60
pubmed: 18170982
Anal Chem. 2006 Feb 1;78(3):779-87
pubmed: 16448051
Analyst. 2015 Nov 21;140(22):7810-7
pubmed: 26462549
Bioinformatics. 2013 Nov 15;29(22):2877-83
pubmed: 23958724
Sci Rep. 2018 Aug 28;8(1):12958
pubmed: 30154509
Talanta. 2014 Dec;130:442-8
pubmed: 25159433
Sci Rep. 2018 Oct 2;8(1):14616
pubmed: 30279541
ALTEX. 2015;32(4):319-26
pubmed: 26536290
Anal Chem. 2014 Aug 5;86(15):7558-65
pubmed: 24992377
Anal Chim Acta. 2018 Oct 5;1026:62-68
pubmed: 29852994
J Pharm Biomed Anal. 2018 Jan 5;147:149-173
pubmed: 28823764
Chem Commun (Camb). 2018 Jun 19;54(50):6728-6749
pubmed: 29888773
Anal Chem. 2009 Feb 15;81(4):1357-64
pubmed: 19170513
Bioanalysis. 2012 Sep;4(18):2249-64
pubmed: 23046267

Auteurs

Teresa Martínez-Sena (T)

Hepatología Experimental, Health Research Institute La Fe, Valencia, Spain.

Giovanna Luongo (G)

Hepatología Experimental, Health Research Institute La Fe, Valencia, Spain.

Daniel Sanjuan-Herráez (D)

Health and Biomedicine, Leitat Technological Center, Valencia, Spain.

José V Castell (JV)

Hepatología Experimental, Health Research Institute La Fe, Valencia, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Departamento de Bioquímica y Biología Molecular, Universidad de Valencia, Valencia, Spain.
Unidad Analítica, Health Research Institute La Fe, Valencia, Spain.

Máximo Vento (M)

Neonatal Research Unit, Health Research Institute La Fe, Valencia, Spain.
Division of Neonatology, University & Polytechnic Hospital La Fe, Valencia, Spain.

Guillermo Quintás (G)

Health and Biomedicine, Leitat Technological Center, Valencia, Spain. gquintas@leitat.org.
Unidad Analítica, Health Research Institute La Fe, Valencia, Spain. gquintas@leitat.org.

Julia Kuligowski (J)

Neonatal Research Unit, Health Research Institute La Fe, Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH